Transcatheter Aortic Valve Implantation in Younger Patients: A New Challenge

Overview

Journal Medicina (Kaunas)

Publisher MDPI

Specialty General Medicine

Date 2021 Sep 28

PMID 34577806

Citations 3

Authors

Giacomo Virgili

Salvatore Mario Romano

Renato Valenti

Angela Migliorini

Pierluigi Stefano

Niccolo Marchionni

Nazario Carrabba

Affiliations

Soon will be listed here.

Abstract

The number of aortic stenosis patients in Western countries is increasing, along with better life conditions and expectancies. Presently, the volume of percutaneous transcatheter aortic valve implantations (TAVIs) is incessantly increasing, and has already overcome the surgical replacement procedure volume. According to the literature, TAVI is a feasible procedure even among low surgical risk patients, and American guidelines have extended the indications for TAVI, including shifting patient evaluations from high/low STS scores to old/young patients, a "paradigm shift" of aortic stenosis evaluation. As a result, low-risk young (<75 years-old) population management could be the next challenge in cardiology. To manage the life conditions of a 65 year old patient affected by aortic stenosis who is undergoing TAVI, one of the most crucial issue will be bioprosthesis durability and the appropriate intervention to make in cases of valve dysfunction or failure.

Citing Articles

Long-term outcomes following transcatheter aortic valve implantation with the Portico self-expanding valve.

Giordano A, Mas-Peiro S, Fichtlscherer S, Schaefer A, Beyer M, Maisano F Clin Res Cardiol. 2023; 113(1):86-93.

PMID: 37391628 PMC: 10808416. DOI: 10.1007/s00392-023-02252-x.

Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve - DurAVR.

Kodali S, Sorajja P, Meduri C, Feldt K, Cavalcante J, Garg P EuroIntervention. 2023; 19(4):e352-e362.

PMID: 37334801 PMC: 10333917. DOI: 10.4244/EIJ-D-23-00282.

A retrospective study on the trends in surgical aortic valve replacement outcomes in the post-transcatheter aortic valve replacement era.

Chahine J, Jedeon Z, Fiocchi J, Shaffer A, Knoper R, John R Health Sci Rep. 2022; 5(3):e660.

PMID: 35620548 PMC: 9124950. DOI: 10.1002/hsr2.660.

References

Baumgartner H, Falk V, Bax J, De Bonis M, Hamm C, Holm P . 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017; 38(36):2739-2791. DOI: 10.1093/eurheartj/ehx391. View

Figulla H, Franz M, Lauten A . The History of Transcatheter Aortic Valve Implantation (TAVI)-A Personal View Over 25 Years of development. Cardiovasc Revasc Med. 2019; 21(3):398-403. DOI: 10.1016/j.carrev.2019.05.024. View

Murray M, Hofmann E, de Rosa R, Mas-Peiro S, Seppelt P, Walther T . Hemodynamic Outcome and Valve Durability Beyond Five Years After Transcatheter Aortic Valve Replacement. J Invasive Cardiol. 2020; 32(3):82-87. DOI: 10.25270/jic/19.00346. View

Yerasi C, Rogers T, Forrestal B, Case B, Khan J, Ben-Dor I . Transcatheter Versus Surgical Aortic Valve Replacement in Young, Low-Risk Patients With Severe Aortic Stenosis. JACC Cardiovasc Interv. 2021; 14(11):1169-1180. DOI: 10.1016/j.jcin.2021.03.058. View

Osnabrugge R, Mylotte D, Head S, Van Mieghem N, Nkomo V, LeReun C . Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013; 62(11):1002-12. DOI: 10.1016/j.jacc.2013.05.015. View

Carroll J, Mack M, Vemulapalli S, Herrmann H, Gleason T, Hanzel G . STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2020; 76(21):2492-2516. DOI: 10.1016/j.jacc.2020.09.595. View

George E, Liacouras P, Rybicki F, Mitsouras D . Measuring and Establishing the Accuracy and Reproducibility of 3D Printed Medical Models. Radiographics. 2017; 37(5):1424-1450. PMC: 5621728. DOI: 10.1148/rg.2017160165. View

Panico R, Giannini C, De Carlo M, Angelillis M, Spontoni P, Pieroni A . Long-term results and durability of the CoreValve transcatheter aortic bioprosthesis: outcomes beyond five years. EuroIntervention. 2018; 14(16):1639-1647. DOI: 10.4244/EIJ-D-18-00779. View

Manoharan G, Walton A, Brecker S, Pasupati S, Blackman D, Qiao H . Treatment of Symptomatic Severe Aortic Stenosis With a Novel Resheathable Supra-Annular Self-Expanding Transcatheter Aortic Valve System. JACC Cardiovasc Interv. 2015; 8(10):1359-1367. DOI: 10.1016/j.jcin.2015.05.015. View

10.

Leon M, Smith C, Mack M, Miller D, Moses J, Svensson L . Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010; 363(17):1597-607. DOI: 10.1056/NEJMoa1008232. View

11.

Leon M, Smith C, Mack M, Makkar R, Svensson L, Kodali S . Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016; 374(17):1609-20. DOI: 10.1056/NEJMoa1514616. View

12.

Ripley B, Kelil T, Cheezum M, Goncalves A, Di Carli M, Rybicki F . 3D printing based on cardiac CT assists anatomic visualization prior to transcatheter aortic valve replacement. J Cardiovasc Comput Tomogr. 2016; 10(1):28-36. PMC: 5573584. DOI: 10.1016/j.jcct.2015.12.004. View

13.

Makkar R, Yoon S, Leon M, Chakravarty T, Rinaldi M, Shah P . Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke. JAMA. 2019; 321(22):2193-2202. PMC: 6563564. DOI: 10.1001/jama.2019.7108. View

14.

Mack M, Leon M, Thourani V, Makkar R, Kodali S, Russo M . Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019; 380(18):1695-1705. DOI: 10.1056/NEJMoa1814052. View

15.

Lederman R, Babaliaros V, Rogers T, Khan J, Kamioka N, Dvir D . Preventing Coronary Obstruction During Transcatheter Aortic Valve Replacement: From Computed Tomography to BASILICA. JACC Cardiovasc Interv. 2019; 12(13):1197-1216. PMC: 6724191. DOI: 10.1016/j.jcin.2019.04.052. View

16.

Toggweiler S, Humphries K, Lee M, Binder R, Moss R, Freeman M . 5-year outcome after transcatheter aortic valve implantation. J Am Coll Cardiol. 2012; 61(4):413-419. DOI: 10.1016/j.jacc.2012.11.010. View

17.

Tang G, Zaid S, Gupta E, Ahmad H, Khan A, Kovacic J . Feasibility of Repeat TAVR After SAPIEN 3 TAVR: A Novel Classification Scheme and Pilot Angiographic Study. JACC Cardiovasc Interv. 2019; 12(13):1290-1292. DOI: 10.1016/j.jcin.2019.02.020. View

18.

Mack M, Leon M, Smith C, Miller D, Moses J, Tuzcu E . 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015; 385(9986):2477-84. DOI: 10.1016/S0140-6736(15)60308-7. View

19.

Kapadia S, Leon M, Makkar R, Tuzcu E, Svensson L, Kodali S . 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015; 385(9986):2485-91. DOI: 10.1016/S0140-6736(15)60290-2. View

20.

Silaschi M, Wendler O, Seiffert M, Castro L, Lubos E, Schirmer J . Transcatheter valve-in-valve implantation versus redo surgical aortic valve replacement in patients with failed aortic bioprostheses. Interact Cardiovasc Thorac Surg. 2016; 24(1):63-70. DOI: 10.1093/icvts/ivw300. View